f3

In search of effective therapies to overcome resistance to Temozolomide in brain tumours

Figure 3. Clonogenic survival of U373V, U373M and HCT 116 cells following challenge (24 h) with temozolomide (TMZ) (A) and N3P (B); (C) representative HCT 116 colonies - control and following exposure of cells to 20 μmol/L N3P